Chemoinformaics analysis of 1(7),2-P-Menthadien-4-Ol
| Molecular Weight | 152.237 | nRot | 1 |
| Heavy Atom Molecular Weight | 136.109 | nRig | 7 |
| Exact Molecular Weight | 152.12 | nRing | 1 |
| Solubility: LogS | -2.087 | nHRing | 0 |
| Solubility: LogP | 2.254 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
| nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 28.1707 |
| nHD | 1 | BPOL | 16.0513 |
| QED | 0.611 |
| Synth | 4.132 |
| Natural Product Likeliness | 3.326 |
| NR-PPAR-gamma | 0.012 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Rejected |
| Pgp-inh | 0.003 |
| Pgp-sub | 0.001 |
| HIA | 0.004 |
| CACO-2 | -4.277 |
| MDCK | 0.0000314 |
| BBB | 0.995 |
| PPB | 0.599313 |
| VDSS | 1.525 |
| FU | 0.431928 |
| CYP1A2-inh | 0.179 |
| CYP1A2-sub | 0.325 |
| CYP2c19-inh | 0.108 |
| CYP2c19-sub | 0.793 |
| CYP2c9-inh | 0.059 |
| CYP2c9-sub | 0.498 |
| CYP2d6-inh | 0.1 |
| CYP2d6-sub | 0.209 |
| CYP3a4-inh | 0.085 |
| CYP3a4-sub | 0.335 |
| CL | 10.687 |
| T12 | 0.633 |
| hERG | 0.031 |
| Ames | 0.086 |
| ROA | 0.068 |
| SkinSen | 0.929 |
| Carcinogencity | 0.89 |
| EI | 0.879 |
| Respiratory | 0.768 |
| NR-Aromatase | 0.049 |
| Antiviral | No |
| Prediction | 0.922663 |